Methylation Sequencing Enhances Interpretation of Clonal Hematopoiesis Dynamics

This 11-minute conference talk from the Cancer Genomics Consortium (CGC) 2024 Annual Meeting features Alyssa Parker discussing how methylation sequencing can improve the understanding of clonal hematopoiesis dynamics. Learn about advanced genomic techniques that help clinicians more accurately diagnose cancer patients based on their underlying genomic alterations, ultimately guiding more appropriate therapy selection. The CGC represents clinical cytogeneticists, molecular geneticists, and molecular pathologists dedicated to education and promoting best practices in clinical cancer genomics, with the vision that all cancer patients receive accurate genomic diagnoses to inform their treatment plans.